Resultados de la búsqueda 121-130 of 2203 for Green Birth Control
... management of congenital heart disease. Genotype ... management option for ... birth because the infant is not suspected to have LQTS before birth.
... birth because the infant is not suspected to have LQTS before birth. ... The investigators have chosen this population ... management option for severe hypertrophic ...
To verify the performance characteristics of anti-Paraneoplastic Pemphigus (PNP) serum and validate its use as a positive control in PNP test. Serum from ...
... birth because the infant is not suspected to have LQTS before birth. ... The investigators have chosen this population ... management and prognosis in peri-partum ...
Drugs used in chemotherapy, such as cisplatin and docetaxel, work in different ways to stop the growth of tumor cells, either by killing the cells or by ...
The results of this trial will provide a foundation for the future development of larger definitive randomized controlled trials. ... birth of first child, etc.
This randomized phase II/III trial studies how well radiation therapy works when given together with cisplatin compared to docetaxel or cetuximab and docetaxel ...
... management of congenital heart disease. Genotype ... birth because the infant is not suspected to have LQTS before birth. ... management, and improve outcomes.
Also, to improve disease control by decreasing the number of spinal relapses for patients who achieve a complete response (CR) or partial response (PR) and ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?